Minor Histocompatibility Antigen Expression on F9 Embryonal Carcinoma Cells Revealed by T-cell Mediated Responses

Overview

Journal Immunogenetics

Specialties Allergy & Immunology
Genetics

Date 1982 Jan 1

PMID 6983494

Citations 3

Authors

M C Simmler

P Avner

J P LEVY

Affiliations

Soon will be listed here.

Citing Articles

Resistance to 402AX teratocarcinoma involves immunity to minor histocompatibility antigens.

Ostrand-Rosenberg S, Clements V Immunogenetics. 1987; 26(1-2):1-5.

PMID: 3301646 DOI: 10.1007/BF00345447.

MHC-unrestricted T-cell cytotoxicity against tumour cells.

Sponaas A, Loveland B, Simpson E Immunology. 1988; 63(2):233-9.

PMID: 3258274 PMC: 1454511.

Differential Hm antigen expression on EC cells and early differentiated derivatives.

Simmler M, Avner P EMBO J. 1985; 4(5):1177-85.

PMID: 2988940 PMC: 554321. DOI: 10.1002/j.1460-2075.1985.tb03757.x.

References

Avner P, Dove W, Dubois P, Gaillard J, Guenet J, Jacob F . The genetics of teratocarcinoma transplantation: tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3. Immunogenetics. 2011; 7(1):103-15. DOI: 10.1007/BF01843995. View

Heyner S, Hunziker R, Zink G . Differential expression of minor histocompatibiility antigens on the surface of the mouse oocyte and preimplantation developmental stages. J Reprod Immunol. 1980; 2(5):269-79. DOI: 10.1016/0165-0378(80)90040-6. View

Shedlovsky A, Clipson L, Vandeberg J, Dove W . Strong teratocarcinoma transplantation loci, Gt-1 and Gt-2, flank H-2. Immunogenetics. 1981; 13(5):413-9. DOI: 10.1007/BF00346022. View

Morello D, Daniel F, Baldacci P, Cayre Y, Gachelin G, Kourilsky P . Absence of significant H-2 and beta 2-microglobulin mRNA expression by mouse embryonal carcinoma cells. Nature. 1982; 296(5854):260-2. DOI: 10.1038/296260a0. View

Forman J, Vitetta E . Absence of H-2 antigens capable of reacting with cytotoxic T cells on a teratoma line expressing a T/t locus antigen. Proc Natl Acad Sci U S A. 1975; 72(9):3661-5. PMC: 433056. DOI: 10.1073/pnas.72.9.3661. View

Avner P, Simmler M . Genetics of teratocarcinoma transplantation. III. Genetic control of resistance to F9 tumor formation in allogeneic hosts. J Reprod Immunol. 1982; 4(1):31-7. DOI: 10.1016/0165-0378(82)90021-3. View

Searle R, Jenkinson E, Johnson M . Immunogenicity of mouse trophoblast and embryonic sac. Nature. 1975; 255(5511):719-20. DOI: 10.1038/255719a0. View

Levine A, Teresky A . Teratocarcinoma transplantation rejection loci: genetic localization of the Gt-1 locus on chromosome 17 and the expression of alternate alleles. Immunogenetics. 1981; 13(5):405-12. DOI: 10.1007/BF00346021. View

Avner P . Genetics of teratocarcinoma transplantation. II. Effect of a semidominant H-2-linked gene lying outside the immediate major histocompatibility complex on tumor formation by the embryonal carcinoma cell line F9 in H-2 congenic pairs. Transplantation. 1980; 30(3):185-90. View

10.

Peck A, Bach F . Mouse cell-mediated lympholysis assay in serum-free and mouse serum-supplemented media: culture conditions and genetic factors. Scand J Immunol. 1975; 4(1):53-62. DOI: 10.1111/j.1365-3083.1975.tb02599.x. View

11.

Zinkernagel R, Oldstone M . Cells that express viral antigens but lack H-2 determinants are not lysed by immune thymus-derived lymphocytes but are lysed by other antiviral immune attack mechanisms. Proc Natl Acad Sci U S A. 1976; 73(10):3666-70. PMC: 431179. DOI: 10.1073/pnas.73.10.3666. View

12.

Bevan M . Priming for a cytotoxic response to minor histocompatibility antigens: antigen specificity and failure to demonstrate a carrier effect. J Immunol. 1977; 118(4):1370-4. View

13.

Simmler M, Avner P . The significance of natural killer activity in the resistance of allogeneic hosts to the embryonal carcinoma cell line F9. Am J Reprod Immunol (1980). 1982; 2(6):301-8. DOI: 10.1111/j.1600-0897.1982.tb00197.x. View

14.

Isa A . Lack of demonstrable H-2 antigens on the surface of teratocarcinoma 402AX of the mouse maintained in vivo. Transplantation. 1976; 21(3):196-8. View